Peptide Reference

How Peptides Are Made

UKPWritten & reviewed by The UK Peptides Editorial Team · Research library, UK Peptides2 min readLast reviewed 2026-08-233 cited sources

The short answer

Solid-phase peptide synthesis anchors the C-terminal residue to a resin bead and adds residues one at a time, each cycle coupling a protected amino acid then deprotecting it for the next. Because coupling is never perfectly efficient, incompleteness compounds across every cycle.

Key facts

Method
Solid-phase peptide synthesis (SPPS)
Direction
C-terminus first (opposite to ribosomes)
Support
Insoluble resin bead
Dominant chemistry
Fmoc protection
Cycle
Couple, wash, deprotect, wash
Failure mode
Deletion sequences

Why a solid support

Merrifield's insight was that anchoring the growing chain to an insoluble bead makes purification trivial between steps: excess reagents and by-products are simply washed away while the peptide stays behind. That removes the isolation step that made solution-phase synthesis impractical for anything long, and it is why the technique won a Nobel Prize and still dominates.

The cycle

Each residue takes four operations. Couple the next protected amino acid to the free amine at the chain's end. Wash away excess. Remove that residue's temporary protecting group to expose a new amine. Wash again. Repeat. A fifteen-residue peptide is fourteen of these cycles, each with its own opportunity to go incompletely.

Research material referenced

BPC-157 5mg, third-party HPLC tested

Buy BPC-157 · £15.99

Why efficiency compounds

This is the arithmetic that governs everything. At 99% coupling efficiency per cycle, a ten-residue peptide finishes at 0.99^9 ≈ 91% full-length. A thirty-residue peptide at the same efficiency reaches 0.99^29 ≈ 75%. At 98% per cycle the thirty-mer drops to about 56%. Small per-step losses become large final ones, which is why long peptides are disproportionately harder and more expensive.

Where deletion sequences come from

A chain that fails to couple in one cycle does not stop. It gets deprotected with everything else and continues in the next cycle, permanently missing one residue. The result is a peptide one residue short, chemically similar to the target and often difficult to separate from it. On a mass spectrum it appears exactly one residue's mass below the parent.

Which residues are difficult

Proline couples slowly because its secondary amine is sterically hindered, which is why BPC-157, with four prolines including a run of three, is harder to synthesise than fifteen residues suggests. Beta-branched residues such as valine and isoleucine are also slow. And non-standard residues like Aib or D-amino acids, as in ipamorelin, are more expensive and less routine.

Then purification

The crude product is cleaved from the resin and purified, almost always by reverse-phase HPLC using trifluoroacetic acid in the mobile phase. That is where the TFA counter-ion comes from, and it is why net peptide content is lower than gross powder weight.

Frequently asked questions

Why are longer peptides so much more expensive?
Coupling efficiency compounds. At 99% per cycle a ten-mer finishes around 91% full-length; a thirty-mer around 75%. Yield falls fast with length.
What is a deletion sequence?
A peptide missing one residue, produced when a coupling step fails. It continues through the remaining cycles and appears one residue's mass below the parent.
Which residues are hardest to couple?
Proline, because its secondary amine is hindered; beta-branched residues like valine and isoleucine; and non-standard residues such as Aib or D-amino acids.

Extended research context

The Peptide Reference deep dive

Deep dive: what 'peptide' actually means

A peptide is a short chain of amino acids linked by peptide bonds, typically 2–50 residues. Above that boundary the molecule is usually called a protein. Peptides can be endogenous (produced by the body) or synthetic (manufactured by solid-phase peptide synthesis, SPPS). The 'research peptide' category refers specifically to synthetic peptides supplied for laboratory use: not medicines, not supplements.

Why HPLC and mass spec together

HPLC (High-Performance Liquid Chromatography) reports the purity of a batch by measuring what percentage of the sample matches the target peptide's retention time. Mass spectrometry independently confirms the target's molecular weight. Together they answer two different questions: 'is it clean?' and 'is it the right molecule?'. A CoA that reports only one is incomplete.

How to read a Certificate of Analysis

A complete peptide CoA lists: batch number, HPLC purity (area %), mass-spec measured mass vs theoretical, water content (Karl Fischer), acetate/counterion content, appearance, and often endotoxin and residual solvents. Learn to spot the missing fields, as that's usually where quality claims fall apart.

Research applications

  • ▸Reference standards for analytical method development
  • ▸Comparator peptides in receptor-binding assays
  • ▸Stability testing of lyophilised material
  • ▸Formulation R&D for topical and aqueous carriers
  • ▸Teaching material for peptide chemistry courses

Handling checklist

  • ✓Confirm HPLC ≥98% and mass-spec identity on CoA
  • ✓Store lyophilised at −20 °C long-term
  • ✓Reconstitute with bacteriostatic or sterile water only
  • ✓Aliquot to minimise freeze/thaw cycles
  • ✓Label vials with date, concentration, and batch

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Buying a peptide without a CoA

Fix: Insist on an in-batch HPLC + mass-spec certificate before purchase.

✗ Using DI water for reconstitution

Fix: Use bacteriostatic (0.9% benzyl alcohol) or sterile water only.

✗ Storing lyophilised vials at room temperature long-term

Fix: Freeze at −20 °C; short-term 2–8 °C is acceptable for weeks, not months.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Related questions researchers ask

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

UKP

Written and reviewed by

The UK Peptides Editorial Team · Research library, UK Peptides

The editorial team is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate. Corrections are made in place and the review date updated.

More Peptide Reference articles

Popular across the research hub

One flagship guide from every other research category.

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.